On Wednesday, Goldman Sachs maintained its Buy rating and $410.00 price target for Sherwin-Williams (NYSE: NYSE:SHW), despite the company reporting third-quarter earnings per share (EPS) of $3.37, which fell short of the Bloomberg consensus of $3.53 and was slightly higher than the $3.20 reported in the same quarter last year.
The Paint Stores Group within Sherwin-Williams saw same-store sales (SSS) grow by 2.2%, including an approximately 1% negative impact from hurricanes. However, the company's other two segments experienced declining sales due to unfavorable foreign exchange rates and reduced do-it-yourself (DIY) volumes.
Goldman Sachs addressed concerns from the third quarter, noting that the Paint Stores Group's modest SSS growth, higher selling, general and administrative (SG&A) costs, cautious comments about the first half of 2025, and a guidance reduction for the fourth quarter, could be seen as bearish signals. The analyst believes these factors may indicate that the consensus estimates for the period might be too optimistic.
Conversely, Goldman Sachs presented a more positive perspective, suggesting that the lower sales growth was due to negative foreign exchange effects and a shift in product mix rather than a failure to achieve price increases.
The firm also highlighted Sherwin-Williams' historical strategy of investing during challenging times to gain market share, an approach that could be beneficial given the potential sale of a North American competitor.
Additionally, the announcement of a 5% price increase for January, which was not factored into consensus models, is expected to contribute to margin expansion that exceeds expectations.
In conclusion, Goldman Sachs recognizes the current challenges, including the impact of rising borrowing rates on the outlook for the first half of 2025. Nevertheless, the firm's medium to long-term outlook for Sherwin-Williams remains positive, with expectations of market share gains and improved pricing power.
In other recent news, Sherwin-Williams has been a topic of discussion among investors following its third-quarter performance and subsequent analysis by Evercore ISI. The company's earnings fell slightly short of expectations, leading to a reduction in the price target from $410 to $400 by Evercore ISI, which maintains an Outperform rating on the stock. Despite the earnings miss, the firm remains optimistic about Sherwin-Williams' prospects, highlighting its strategy of gaining market share and building a competitive moat.
On the earnings front, Sherwin-Williams reported consolidated sales growth, improved gross margins, and increased earnings per share (EPS) in the third quarter of 2024. The company is maintaining its full-year EPS guidance, despite facing temporary store closures due to hurricanes. To address rising costs, Sherwin-Williams announced a 5% price increase across all segments.
In addition to these financial updates, the company is preparing for a modest recovery in the second half of 2025, driven by improving economic conditions and home equity. Despite some challenges, Sherwin-Williams returned $631 million to shareholders through dividends and share repurchases.
InvestingPro Insights
Sherwin-Williams' financial metrics and market position offer additional context to Goldman Sachs' analysis. According to InvestingPro data, the company boasts a substantial market capitalization of $91.16 billion, reflecting its prominent status in the chemicals industry. The company's revenue for the last twelve months as of Q3 2024 stood at $23.05 billion, with a modest growth of 0.1%, aligning with the cautious outlook mentioned in the article.
InvestingPro Tips highlight Sherwin-Williams' strong dividend history, having raised its dividend for 32 consecutive years and maintained payments for 46 years. This demonstrates the company's financial stability and commitment to shareholder returns, which could be reassuring for investors despite the recent earnings miss.
However, the stock's valuation metrics suggest a premium pricing. With a P/E ratio of 38.05 and trading at a high Price / Book multiple, Sherwin-Williams appears to be trading at a high earnings multiple relative to its near-term growth prospects. This valuation could be justified by the company's market position and Goldman Sachs' expectations of future market share gains and improved pricing power.
For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips that could provide deeper insights into Sherwin-Williams' financial health and market prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.